ADIPOQ and gestational diabetes: Thus, the primary objectives of this study were to evaluate the effect of the newborn ADIPOQ rs266729 polymorphism on newborn weight status, to assess the impact of maternal glycemic and lipid metabolism and maternal adiponectin levels at 24 to 28 weeks of gestation and at birth on newborn weight, and to examine the connection between cord blood adiponectin and newborn weight in a cohort of pregnant women with GDM and their newborns.